Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Associations of tubal ligation and hysterectomy with serum androgen and estrogen metabolites among postmenopausal women in the Women's Health Initiative Observational Study
  2. Geczik, Ashley M; Michels, Kara A; Anderson, Garnet L; Falk, Roni T; Farland, Leslie V; Manson, JoAnn E; Shadyab, Aladdin H; Pfeiffer, Ruth M; Xu,Xia; Trabert, Britton
  3. Cancer Causes & Control : CCC. 2024, May 21;
  1. 2.   Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
  2. Wilkinson, Scott; Ye, Huihui; Karzai, Fatima; Harmon,Stephanie; Terrigino, Nicholas T; VanderWeele, David J; Bright, John R; Atway, Rayann; Trostel, Shana Y; Carrabba, Nicole V; Whitlock, Nichelle C; Walker, Stephanie M; Lis, Rosina T; Abdul Sater, Houssein; Capaldo, Brian J; Madan, Ravi A; Gulley, James L; Chun, Guinevere; Merino, Maria J; Pinto, Peter A; Salles, Daniela C; Kaur, Harsimar B; Lotan, Tamara L; Venzon, David J; Choyke, Peter L; Turkbey, Baris; Dahut, William L; Sowalsky, Adam G
  3. European Urology. 2021, Dec; 80(6): 746-757.
  1. 3.   Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [F-18]DCFPyL PET Imaging
  2. Roy, Jyoti; White, Margaret E.; Basuli, Falguni; Opina, Ana Christina L.; Wong, Karen; Riba, Morgan; Ton, Anita T.; Zhang, Xiang; Jansson, Keith H.; Edmondson,Elijah; Butcher,Donna; Lin, Frank I.; Choyke, Peter L.; Kelly, Kathleen; Jagoda, Elaine M.
  3. Molecular Imaging and Biology. 2021, Oct; 23(5): 745-755.
  1. 4.   Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
  2. Schmidt, Karyn; Weidmann, Chase A; Hilimire, Thomas A; Yee, Elaine; Hatfield, Breanne M; Schneekloth,Jay; Weeks, Kevin M; Novina, Carl D
  3. Cell reports. 2020, Jan 14; 30(2): 541-554.e5.
  1. 5.   Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study
  2. Trabert, Britton; Michels, Kara A; Anderson, Garnet L; Brinton, Louise A; Falk, Roni T; Geczik, Ashley M; Harris, Holly R; Pan, Kathy; Pfeiffer, Ruth M; Qi, Lihong; Rohan, Thomas; Wentzensen, Nicolas; Xu,Xia
  3. International journal of cancer. 2019, Oct 15; 145(8): 2051-2060.
  1. 6.   mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy
  2. Gold, Samuel A.; VanderWeele, David J.; Harmon,Stephanie; Bloom, Jonathan B.; Karzai, Fatima; Hale, Graham R.; Marhamati, Shawn; Rayn, Kareem N.; Mehralivand, Sherif; Merino, Maria J.; Gulley, James L.; Bilusic, Marijo; Madan, Ravi A.; Choyke, Peter L.; Turkbey, Baris; Dahut, William; Pinto, Peter A.
  3. Urologic oncology. 2019, Jun; 37(6):
  1. 7.   Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model
  2. Zhao, Hong; Zhou, Ling; Li, Lin; Coon, John; Chatterton, Robert T.; Brooks, David C.; Jiang, Enze; Liu, Li; Xu, Xia; Dong, Zhiyong; DeMayo, Francesco J.; Stulberg, Jonah J.; Tourtellotte, Warren G.; Bulun, Serdar E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Oct 30; 115(44): E10427-E10436.
  1. 8.   Generation and characterization of monoclonal antibodies that recognize human and murine supervillin protein isoforms
  2. Smith, Tara C.; Saul, Rick; Barton, Elisabeth R.; Luna, Elizabeth J.
  3. PloS one. 2018, Oct 17; 13(10):
  1. 9.   Androgen alleviates neurotoxicity of ß-amyloid peptide (Aß) by promoting microglial clearance of Aß and inhibiting microglial inflammatory response to Aß
  2. Yao, Peng-Le; Zhuo, Shu; Mei, Hong; Chen, Xiao-Fang; Li, Na; Zhu, Teng-Fei; Chen, Shi-Ting; Wang, Jiming; Hou, Rui-Xing; Le, Ying-Ying
  3. CNS Neuroscience & Therapeutics. 2017, NOV; 23(11): 855-865.
  1. 10.   Methoxychalcone inhibitors of androgen receptor translocation and function
  2. Kim, Y. S.; Kumar, V.; Lee, S.; Iwai, A.; Neckers, L.; Malhotra, S. V.; Trepel, J. B.
  3. Bioorganic & Medicinal Chemistry Letters. 2012, Mar; 22(5): 2105-2109.
  1. 11.   Recombinant Origin of the Retrovirus XMRV
  2. Paprotka, T.; Delviks-Frankenberry, K. A.; Cingoz, O.; Martinez, A.; Kung, H. J.; Tepper, C. G.; Hu, W. S.; Fivash, M. J.; Coffin, J. M.; Pathak, V. K.
  3. Science. 2011, Jul; 333(6038): 97-101.
  1. 12.   RanBPM is essential for mouse spermatogenesis and oogenesis
  2. Puverel, S.; Barrick, C.; Dolci, S.; Coppola, V.; Tessarollo, L.
  3. Development. 2011, Jun; 138(12): 2511-2521.
  1. 13.   Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells
  2. Volate, S. R.; Kawasaki, B. T.; Hurt, E. M.; Milner, J. A.; Kim, Y. S.; White, J.; Farrar, W. L.
  3. Molecular Cancer Therapeutics. 2010, Feb; 9(2): 461-470.
  1. 14.   Epigenetic gene regulation in stem cells and correlation to cancer
  2. Mathews, L. A.; Crea, F.; Farrar, W. L.
  3. Differentiation. 2009, Jul; 78(1): 1-17.
  1. 15.   Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer
  2. Yeager, M.; Deng, Z. M.; Boland, J.; Matthews, C.; Bacior, J.; Lonsberry, V.; Hutchinson, A.; Burdett, L. A.; Qi, L. Q.; Jacobs, K. B.; Gonzalez-Bosquet, J.; Berndt, S. I.; Hayes, R. B.; Hoover, R. N.; Thomas, G.; Hunter, D. J.; Dean, M.; Chanock, S.
  3. Human Genetics. 2009 126(6): 743-750.
  1. 16.   Genetic variants in the 8q24 locus and risk of testicular germ cell tumors
  2. Cook, M. B.; Graubard, B. I.; Quraishi, S. M.; Yeager, M.; Chanock, S. J.; Crenshaw, A.; Erickson, R. L.; Rubertone, M. V.; Thomas, G.; McGlynn, K. A.
  3. Human Genetics. 2008 123(4): 409-418.
  1. 17.   Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide
  2. Varricchio, L.; Migliaccio, A.; Castoria, G.; Yamaguchi, H.; de Falco, A.; Di Domenico, M.; Giovannelli, P.; Farrar, W.; Appella, E.; Auricchio, F.
  3. Molecular Cancer Research. 2007, Nov; 5(11): 1213-1221.
  1. 18.   Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets
  2. Ma, B. Y.; Pan, Y. P.; Zheng, J.; Levine, A. J.; Nussinov, R.
  3. Nucleic Acids Research. 2007, May; 35(9): 2986-3001.
  1. 19.   Stem cells in prostate cancer - Resolving the castrate-resistant conundrum and implications for hormonal therapy
  2. Sharifi, N.; Kawasaki, B. I.; Hurt, E. M.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2006, Aug; 5(8): 901-906.
  1. 20.   Molecular alterations in primary prostate cancer after androgen ablation therapy
  2. Best, C. J. M.; Gillespie, J. W.; Yi, Y. J.; Chandramouli, G. V. R.; Perlmutter, M. A.; Gathright, Y.; Erickson, H. S.; Georgevich, L.; Tangrea, M. A.; Duray, P. H.; Gonzalez, S.; Velasco, A.; Linehan, W. M.; Matusik, R. J.; Price, D. K.; Figg, W. D.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Clinical Cancer Research. 2005, OCT 1; 11(19, Part 1): 6823-6834.
  1. 21.   The role of IKK in constitutive activation of NF-kappa B transcription factor in prostate carcinoma cells
  2. Gasparian, A. V.; Yao, Y. J.; Kowalczyk, D.; Lyakh, L. A.; Karseladze, A.; Slaga, T. J.; Budunova, I. V.
  3. Journal of Cell Science. 2002 115(1): 141-151.
  1. 22.   PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer
  2. Srikantan, V.; Zou, Z. Q.; Petrovics, G.; Xu, L.; Augustus, M.; Davis, L.; Livezey, J. K.; Connell, T.; Sesterhenn, I. A.; Yoshino, K.; Buzard, G. S.; Mostofi, F. K.; McLeod, D. G.; Moul, J. W.; Srivastava, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2000 97(22): 12216-12221.
  1. 23.   Comparisons of genomic structures and chromosomal locations of the mouse aldose reductase and aldose reductase-like genes
  2. Ho, H. T. B.; Jenkins, N. A.; Copeland, N. G.; Gilbert, D. J.; Winkles, J. A.; Louie, H. W. Y.; Lee, F. K.; Chung, S. S. M.; Chung, S. K.
  3. European Journal of Biochemistry. 1999 259(3): 726-730.
  1. 24.   A new human prostate carcinoma cell line, 22R upsilon 1
  2. Sramkoski, R. M.; Pretlow, T. G.; Giaconia, J. M.; Pretlow, T. P.; Schwartz, S.; Sy, M. S.; Marengo, S. R.; Rhim, J. S.; Zhang, D. S.; Jacobberger, J. W.
  3. In Vitro Cellular & Developmental Biology.Animal. 1999 35(7): 403-409.
  1. 25.   Development and Characterization of a Mouse Prostate Adenocarcinoma Cell Line - Ductal Formation Determined By Extracellular Matrix
  2. Jorcyk, C. L.; Liu, M. L.; Shibata, M. A.; Maroulakou, I. G.; Komschlies, K. L.; McPhaul, M. J.; Resau, J. H.; Green, J. E.
  3. Prostate. 1998 34(1): 10-22.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel